Darwin Global Management, Ltd.
Q1 2024 13F-HR Holdings
Net value change ($000)
+241,684
(47.4%)
New positions
9
Sold out positions
5
Turnover %
104.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PCVX | 151,486 | 415.9% |
| NUVL | 103,656 | 2441.3% |
| BHVN | 80,776 | NEW |
| ALPINE IMMUNE SCIENCES, INC. | 78,567 | NEW |
| BEAM | 70,032 | NEW |
| APGE | 55,300 | NEW |
| KROS | 52,897 | 125.5% |
| XNCR | 24,557 | NEW |
| SYRE | 17,948 | NEW |
| Elevation Oncology, Inc. | 11,968 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Ambrx Biopharma, Inc. | -237,646 | -100.0% |
| TGTX | -69,116 | -100.0% |
| MLTX | -62,763 | -100.0% |
| CYTK | -50,094 | -100.0% |
| SpringWorks Therapeutics, Inc. | -7,035 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|